Netherlands Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
All the vital news, analysis, and commentary curated by our industry experts.
Netherlands Healthcare Market Overview
The Dutch pharmaceutical market size was $5.7 billion and is expected to grow at a CAGR of more than 2% during 2022-2027. The Dutch medical devices market was valued at $4.0 billion in 2021 and is expected to grow at a CAGR of more than 3% during 2022-2027. In 2022, the Dutch government invested $325 million in preclinical cancer treatment development. The government intends to promote the expansion of the Dutch National Growth Fund in order to provide biotechnology with specific capabilities that will speed up the development of oncology prospects. In 2021, the Netherlands developed a Personal Health Train platform that provides access to health data for researchers and innovators in the field of healthcare. It allows for limited data access while following privacy laws to promote patient participation.
The Dutch pharmaceutical market offers great opportunities for pharmaceutical companies owing to the country’s enhanced investments in the R&D sector. The growth of the pharmaceutical market is attributed to the increased usage of medications for the treatment of chronic diseases due to the country’s aging demographics.
Netherlands Pharmaceutical Market Outlook
To gain more information on the Netherlands pharmaceutical market forecast, download a free report sample
Netherlands Medical Devices Market Outlook
To gain more information on the Netherlands medical devices market forecast, download a free report sample
The Netherlands healthcare market research report is an essential source of information on the analysis of the healthcare, regulatory, and reimbursement landscape in the Netherlands. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.
Netherlands Pharmaceuticals Market Report Overview
|Market Size (2020)||$5.7 billion|
|Key Segments||Generics, Biologics, Biosimilars, and Over-the-Counter (OTC) Medicines|
|Key Import Partners||Germany, the US, Belgium, Ireland, and Switzerland|
|Key Export Partners||Germany, the US, Italy, Spain, and France|
|Leading Players||Sanofi, Pfizer, GlaxoSmithKline (GSK), Novartis, and Pharming Group NV|
Netherlands Medical Devices Market Report Overview
|Market Size (2021)||$4.0 billion|
|Key Segments||Hospital Supplies, Wound Care Management, Cardiovascular Devices, Orthopedic Devices, General Surgery Devices, and Others|
|Leading Players||Fresenius SE & Co., Abbott, Siemens Healthineers, GE Healthcare, and Qiagen|
Netherlands Pharmaceuticals Market Segmentation by Import and Export Partners
The key import partners of the Netherlands pharmaceuticals market are Germany, the US, Belgium, Ireland, and Switzerland. Germany accounts for the highest percentage of the import business. The key export partners of the Netherlands pharmaceuticals market are Germany, the US, Italy, Spain, and France. Germany also accounts for the highest percentage of the export business.
Netherlands Pharmaceuticals Market Analysis by Import Partners
For more import partner insights into the Netherlands pharmaceuticals market, download a free report sample
Netherlands Pharmaceuticals Market Analysis by Export Partners
For more export partner insights into the Netherlands pharmaceuticals market, download a free report sample
Netherlands Pharmaceuticals Market Segments
The key segments in the Netherlands pharmaceuticals market are generics, biologics, biosimilars, and over-the-counter (OTC) medicines. In September 2022, Synthon, a generic drug producer based in the Netherlands, succeeded in a jurisdiction claim for marketing authorization of a drug sold under the brand name Copaxone against Teva. The drug is used for the treatment of multiple sclerosis.
Netherlands Pharmaceuticals Market – Competitive Landscape
The leading players in the Netherlands pharmaceuticals market are Sanofi, Pfizer, GlaxoSmithKline (GSK), Novartis, and Pharming Group NV. Pfizer was the leading player among them in terms of net sales value.
Netherlands Pharmaceuticals Market Analysis by Players
To know more about leading players in the Netherlands pharmaceuticals market, download a free report sample
Netherlands Medical Devices Market Segments
The key segments in the Netherlands medical devices market are hospital supplies, wound care management, cardiovascular devices, orthopedic devices, general surgery devices, and others. In 2021, hospital supplies had the highest share in the Netherlands medical devices market.
Netherlands Medical Devices Market Analysis by Segments
For more segment insights into the Netherlands medical devices market, download a free report sample
Netherlands Medical Devices Market – Competitive Landscape
The major players in the medical devices market of the Netherlands are Fresenius SE & Co., Abbott, Siemens Healthineers, GE Healthcare, and Qiagen. Fresenius SE & Co. had the highest share in the Netherlands devices market.
Netherlands Medical Devices Market Analysis by Players
To know more about leading players in the Netherlands medical devices market, download a free report sample
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
- Develop business strategies by understanding the trends shaping and driving the Netherlands healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the Netherlands healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Table of Contents
1. Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights – Facts about the Netherlands Healthcare Market
2.3 Key Highlights: Healthcare Startups in the Netherlands
2.4 Key Events: The Netherlands Healthcare Timeline, 2016–22
2.5 Key Events: The Netherlands Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020–22
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, the Netherlands, 2021
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market – Overview
3.2 Pharmaceutical Market – Exports
3.3 Pharmaceutical Market – Imports
3.4 Pharmaceutical Market – Supply Channels, the Netherlands
3.5 Pharmaceutical Market – Market Segments
3.6 Pharmaceutical Market – Market Segments, Generics, the Netherlands
3.7 Pharmaceutical Market – Market Segments, Biologics and Biosimilars, the Netherlands
3.8 Pharmaceutical Market – Market Segments, OTC Medicines, the Netherlands
3.9 COVID-19 Epidemiology, the Netherlands
3.10 COVID-19 Impact and Developments in the Healthcare Market, the Netherlands
3.11 Pharmaceutical Market – Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market – Overview
4.2 Medical Device Market – Major Segments
4.3 Medical Device Market – Hospital Supplies Market
4.4 Medical Device Market – Cardiovascular Devices Market
4.5 Medical Device Market – Orthopedic Devices Market
4.6 Medical Device Market – General Surgery Market
4.7 Medical Device Market – Wound Care Management Market
4.8 Medical Devices Market – Diagnostic Market
4.9 Medical Devices Market – Major Players
5. Pharmaceutical and Medical Devices Market – Drivers and Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, the Netherlands, 2021–22
6.2 Deal Analysis: Medical Device Market, the Netherlands, 2021–22
7. HealthTech Landscape
7.1 HealthTech Landscape, the Netherlands
7.2 HealthTech Deals Landscape, the Netherlands
7.3 Key HealthTech Deals, the Netherlands
7.4 Adoption of Technology in Healthcare, the Netherlands
7.5 Digital Statistics, the Netherlands
7.6 Regulatory Scenario Covering Use of Technology in Healthcare, the Netherlands
7.7 HealthTech Landscape: Benefits and Risks, the Netherlands
8. Market Access
8.1 Overview of Healthcare System, the Netherlands
8.2 Reimbursement Landscape, the Netherlands
8.3 Reimbursement Process, the Netherlands
8.4 Overview of Insurance Providers, the Netherlands
8.5 Healthcare Spending and Prescription Drug Price Trends, the Netherlands
8.6 Pricing Policies, the Netherlands
8.7 Market Access: Key Events Timeline, the Netherlands, 2010–21
8.8 Regulatory Landscape, the Netherlands
8.8.1 Marketing Authorization for Pharmaceutical Products, the Netherlands
8.8.2 Marketing Authorization for Pharmaceutical Products (Centralized Procedure), the Netherlands
8.8.3 Marketing Authorization for Pharmaceutical Products (Decentralized Procedure), the Netherlands
8.8.4 Marketing Authorization for Pharmaceutical Products (Mutual Recognition Procedure), the Netherlands
8.8.5 Marketing Authorization for Medical Devices, the Netherlands
8.8.6 Intellectual Property Rights, Patent, the Netherlands
8.8.7 Intellectual Property Rights, Trademark, the Netherlands
8.8.8 Clinical Trial Regulation Process, the Netherlands
8.8.9 Pharmaceutical Clinical Trials Landscape, the Netherlands
8.8.10 Medical Devices Clinical Trials Landscape, the Netherlands
8.8.11 Pharmaceutical Import and Export, the Netherlands
8.8.12 Pharmaceutical Advertising Regulations, the Netherlands
8.8.13 Pharmacy Regulations, the Netherlands
8.8.14 Labeling and Packaging Regulations, the Netherlands
9. Country Healthcare Landscape
9.1 The Netherlands Healthcare Policy Highlights
9.2 Healthcare Facilities, the Netherlands
9.3 Healthcare Resources, the Netherlands
9.4 Life Expectancy and Immunization Rate, the Netherlands
9.5 Environmental Health, the Netherlands
9.6 Healthcare Personnel, the Netherlands
9.7 Disease Burden, the Netherlands
9.8 Healthcare Expenditure, the Netherlands
10 Trade Associations, the Netherlands
11 Trade Fairs, the Netherlands
12 Opportunities and Challenges
13.1 Research Methodology
13.1.2 Secondary Research
13.3 About GlobalData
13.4 Contact Us
Frequently asked questions
What was the Netherlands pharmaceuticals market size in 2020?
The pharmaceutical market size in the Netherlands was valued at $5.7 billion in 2020.
What is the Netherlands pharmaceuticals market growth rate?
The Netherlands pharmaceutical market is expected to grow at a CAGR of more than 2% during 2022-2027.
What are the key segments in the Netherlands pharmaceuticals market?
The key segments in the Netherlands pharmaceuticals market are generics, biologics, biosimilars, and over-the-counter (OTC) medicines.
Who are the key import and export partners in the Netherlands pharmaceuticals market?
The key import partners of the Netherlands pharmaceuticals market are Germany, the US, Belgium, Ireland, and Switzerland. The key export partners of the Netherlands are Germany, the US, Italy, Spain, and France.
Who are the leading players in the Netherlands pharmaceuticals market?
The leading players in the Netherlands pharmaceuticals market are Sanofi, Pfizer, GlaxoSmithKline (GSK), Novartis, and Pharming Group NV.
What was the Netherlands medical devices market size in 2021?
The medical devices market size in the Netherlands was valued at $4.0 billion in 2021.
What is the Netherlands medical devices market growth rate?
The medical devices market in the Netherlands is expected to achieve a CAGR of more than 3% during 2022-2027.
What are the key segments in the Netherlands medical devices market?
The key segments in the Netherlands medical devices market are hospital supplies, wound care management, cardiovascular devices, orthopedic devices, general surgery devices, and others.
Who are the leading players in the Netherlands medical devices market?
The leading players in the Netherlands medical devices market are Fresenius SE & Co., Abbott, Siemens Healthineers, GE Healthcare, and Qiagen.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.